RCS - Tekcapital plc - MicroSalt wins award

TekcapitalAnnouncement

20/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221220:nRST2400Ka&default-theme=true

RNS Number : 2400K  Tekcapital plc  20 December 2022

 

20 December 2022

Tekcapital Plc

("Tekcapital", the "Company" or "the Group")

 

Portfolio Company Update: MicroSalt, Ltd. ("MicroSalt")

MicroSalt® Wins 2022 Sodium Reduction Technology Provider of the Year

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property
investment group focused on creating valuable products that can improve
people's lives, is pleased to announce that MicroSalt® has been named the
2022 Sodium Reduction Technology Provider of the Year by Global Health &
Pharma (https://www.ghp-news.com/issues/fitness-and-nutrition-awards-2022/10/)
.

 

 

Launched in 2017, Global Health & Pharma
(https://www.ghp-news.com/awards/fitness-and-nutrition-awards/) conducts
extensive research and fact-checking to determine award recipients and the
annual award is based on merit, not votes. MicroSalt provides a much-needed
salt that enables food manufacturers the opportunity to lower the sodium
content of their products without any impact on flavour. With 31% of all
adults globally suffering from high blood pressure and cardiovascular disease,
and with efforts mounting from governments across the globe to lower sodium,
MicroSalt offers a truly revolutionary worldwide solution for both
manufactures and consumers.

 

"We are extremely proud of this award. It reflects our commitment to making a
dent in one of the world's leading health problems. Sodium is a very real,
worldwide issue and we are proud to lead the fight against excess sodium."
Said Rick Guiney, CEO of MicroSalt®.

 

About MicroSalt®

MicroSalt, is the developer and manufacturer of a proprietary low-sodium salt
called MicroSalt®. We are passionate about improving peoples' lives with
better-for-you seasonings and snacks by taking the lead in the industry by
providing the best low-sodium salt solution, based on the mechanical
transformation of the salt particle itself. This solution is the only one that
delivers real salt flavour because it is salt. Our new patented technology
produces salt crystals that are approximately one hundred times smaller than
typical table salt, delivering a powerful saltiness as the micro-grains
dissolve in the mouth, with approximately 50% less sodium consumption.
Additionally, the ultra-small particle size enhances product adhesion, which
reduces waste and provides improved flavor consistency. MicroSalt® and
SaltMe® are registered trademarks of MicroSalt Inc.

 

To learn more about MicroSalt please visit https://www.microsaltinc.com
(https://www.microsaltinc.com)

 

Tekcapital owns 97.2% of the share capital of MicroSalt Ltd. and 73% of
MicroSalt Inc. its U.S. subsidiary.

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed
discoveries that can enhance people's lives and provides a range of technology
transfer services to help organisations evaluate and commercialise new
technologies. Tekcapital is quoted on the AIM market of the London Stock
Exchange (AIM: symbol TEK) and is headquartered in the UK. For more
information, please visit www.tekcapital.com (http://www.tekcapital.com) .

LEI: 213800GOJTOV19FIFZ85

 

For further information, please contact:

 Tekcapital Plc                                                                                                          Via Flagstaff IR
 Clifford M. Gross, Ph.D.

 SP Angel  Corporate Finance                                                                                             +44 (0) 20 3470 0470
 LLP
 (Nominated Adviser and Broker)
 Richard Morrison / Charlie Bouverat (Corporate Finance)

 Rob Rees (Corporate Broking)

 

Flagstaff Strategic and Investor
Communications
       +44 (0)207 129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

This press release is for informational purposes only. The information herein
does not constitute investment advice nor an offer to invest and may contain
statements related to our future business and financial performance and future
events or developments involving MicroSalt that may constitute forward-looking
statements. These statements may be identified by words such as "expect,"
"look forward to," "anticipate" "intend," "plan," "believe," "seek,"
"estimate," "will," "project" or words of similar meaning. We may also make
forward-looking statements in other reports, in presentations, in material
delivered to customers, stakeholders and in press releases. In addition, our
representatives may from time to time make oral forward-looking statements.
Such statements may be based on the current expectations and certain
assumptions of MicroSalt's and/or Tekcapital's management. Please note that
these are subject to a number of risks, uncertainties and factors, including,
but not limited to those described in various disclosures. Should one or more
of these risks or uncertainties materialize, or should underlying expectations
not occur or assumptions prove incorrect, actual results, performance or
achievements of MicroSalt or Tekcapital may vary materially from those
described explicitly or implicitly in the relevant forward-looking statement.
Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to
update or revise these forward-looking statements in light of developments
which differ from those anticipated.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFFFSIFALALIF